文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

1990 年至 2019 年与年龄相关的黄斑变性疾病负担的趋势和差异:2019 年全球疾病负担研究的结果。

Trends and disparities in disease burden of age-related macular degeneration from 1990 to 2019: Results from the global burden of disease study 2019.

机构信息

Department of Ophthalmology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.

出版信息

Front Public Health. 2023 Apr 17;11:1138428. doi: 10.3389/fpubh.2023.1138428. eCollection 2023.


DOI:10.3389/fpubh.2023.1138428
PMID:37265519
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10231224/
Abstract

OBJECTIVES: This study aims to estimate the trends and disparities in the worldwide burden for health of AMD, overall and by age, sex, socio-demographic index (SDI), region, and nation using prevalence and years lived with disability (YLDs) from Global Burden of Disease (GBD) study 2019. METHODS: This retrospective study presents the prevalent AMD cases and YLDs from 1990-2019, as well as the age-standardized prevalence rate (ASPR) and age-standardized YLD rate (ASYR) of AMD. To measure changes over time, estimated annual percentage changes (EAPCs) of the age-standardized rates (ASRs) were analyzed globally, then studied further by sex, SDI, region, and nation. We included data from the 2019 Global Burden of Disease (GBD) database to examine AMD prevalence and YLDs from 1990-2019 in 204 countries and territories, as well as demographic information such as age, sex, SDI, region, and nation. RESULTS: Globally, the number of prevalent AMD cases increased from 3,581,329.17 (95% uncertainty interval [UI], 3,025,619.4-4,188,835.7) in 1990 to 7,792,530 (95% UI, 6,526,081.5-9,159,394.9) in 2019, and the number of YLDs increased from 296,771.93 (95% uncertainty interval [UI], 205,462.8-418,699.82) in 1990 to 564,055.1 (95% UI, 392,930.7-789,194.64) in 2019. The ASPR of AMD had a decreased trend with an EAPC of -0.15 (95% confidence interval [CI], -0.2 to -0.11) from 1990 to 2019, and the ASYR of AMD showed a decreased trend with an EAPC of -0.71 (95% confidence interval [CI], -0.78 to -0.65) during this period. The prevalence and YLDs of AMD in adults over 50 years of age showed a significant increase. The prevalence and YLDs of AMD were significantly higher in females than males, overall. The ASPRs and ASYRs in low SDI regions was greater than in high SDI regions from 1990 to 2019. In addition, increases in prevalence and YLDs differed by regions and nations, as well as level of socio-economic development. CONCLUSION: The number of prevalent cases and YLDs due to AMD increased over 30 years and were directly linked to age, sex, socio-economic status, and geographic location. These findings can not only guide public health work but also provide an epidemiological basis for global strategy formulation regarding this global health challenge.

摘要

目的:本研究旨在使用 2019 年全球疾病负担研究(GBD)的数据,评估全球年龄相关性黄斑变性(AMD)的疾病负担趋势和差异,包括总体情况以及按年龄、性别、社会人口指数(SDI)、地区和国家划分的情况,使用的指标为患病率和伤残调整生命年(YLDs)。

方法:本回顾性研究报告了 1990 年至 2019 年的 AMD 发病病例和 YLDs,以及 AMD 的年龄标准化患病率(ASPR)和年龄标准化 YLD 率(ASYR)。为了衡量随时间的变化,我们分析了全球年龄标准化率(ASRs)的估计年变化百分比(EAPCs),然后按性别、SDI、地区和国家进一步研究。我们纳入了 2019 年全球疾病负担(GBD)数据库的数据,以研究 204 个国家和地区 1990 年至 2019 年的 AMD 患病率和 YLDs,以及年龄、性别、SDI、地区和国家等人口统计信息。

结果:全球范围内,AMD 的发病病例数从 1990 年的 3581329.17(95%置信区间 [CI],3025619.4-4188835.7)增加到 2019 年的 7792530(95%CI,6526081.5-9159394.9),YLDs 从 1990 年的 296771.93(95%CI,205462.8-418699.82)增加到 2019 年的 564055.1(95%CI,392930.7-789194.64)。AMD 的 ASPR 呈下降趋势,EAPC 为-0.15(95%CI,-0.2 至-0.11),1990 年至 2019 年期间,ASYR 呈下降趋势,EAPC 为-0.71(95%CI,-0.78 至-0.65)。50 岁及以上成年人的 AMD 患病率和 YLDs 显著增加。总体而言,女性的 AMD 患病率和 YLDs 明显高于男性。1990 年至 2019 年,低 SDI 地区的 ASPRs 和 ASYRs 高于高 SDI 地区。此外,患病率和 YLDs 的增加因地区和国家以及社会经济发展水平而异。

结论:30 多年来,AMD 的发病病例和 YLDs 数量增加,与年龄、性别、社会经济地位和地理位置直接相关。这些发现不仅可以指导公共卫生工作,还可以为制定全球战略提供流行病学依据,以应对这一全球性健康挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a06/10231224/46b22d8142d4/fpubh-11-1138428-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a06/10231224/6d921f60177b/fpubh-11-1138428-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a06/10231224/8bf29942409b/fpubh-11-1138428-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a06/10231224/d35b80fed606/fpubh-11-1138428-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a06/10231224/46b22d8142d4/fpubh-11-1138428-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a06/10231224/6d921f60177b/fpubh-11-1138428-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a06/10231224/8bf29942409b/fpubh-11-1138428-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a06/10231224/d35b80fed606/fpubh-11-1138428-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a06/10231224/46b22d8142d4/fpubh-11-1138428-g004.jpg

相似文献

[1]
Trends and disparities in disease burden of age-related macular degeneration from 1990 to 2019: Results from the global burden of disease study 2019.

Front Public Health. 2023

[2]
Global incidence, prevalence, and disability of vertebral fractures: a systematic analysis of the global burden of disease study 2019.

Spine J. 2022-5

[3]
Spinal Cord Injury: The Global Incidence, Prevalence, and Disability From the Global Burden of Disease Study 2019.

Spine (Phila Pa 1976). 2022-11-1

[4]
Global, regional, and national burden of incidence, prevalence, and years lived with disability for facial fractures from 1990 to 2019: a systematic analysis for the Global Burden of Disease study 2019.

BMC Oral Health. 2024-4-10

[5]
The global burden of traumatic amputation in 204 countries and territories.

Front Public Health. 2023

[6]
Epidemiology and burden of pelvic fractures: Results from the Global Burden of Disease Study 2019.

Injury. 2023-2

[7]
Global, regional and national burden of gastroesophageal reflux disease, 1990-2019: update from the GBD 2019 study.

Ann Med. 2022-12

[8]
Global, regional, and national time trends in incidence, prevalence, years lived with disability for uterine fibroids, 1990-2019: an age-period-cohort analysis for the global burden of disease 2019 study.

BMC Public Health. 2023-5-19

[9]
Global, regional, and national burden of infertility attributable to PCOS, 1990-2019.

Hum Reprod. 2024-1-5

[10]
Secular Trends in Musculoskeletal Rehabilitation Needs in 191 Countries and Territories From 1990 to 2019.

JAMA Netw Open. 2022-1-4

引用本文的文献

[1]
Global trends and disparities in burden of blindness and vision loss caused by non-communicable diseases from 1990 to 2021, and forecasts to 2045: a systematic analysis for the global burden of disease study 2021.

Front Med (Lausanne). 2025-6-19

[2]
The burden of age-related macular degeneration and its socioeconomic associates in the Eastern Mediterranean Region from 1990 to 2021.

Sci Rep. 2025-7-1

[3]
Tracing global progress: two decades of age-related macular degeneration research.

Int J Ophthalmol. 2025-5-18

[4]
An analysis of the global, regional, and national burden of blindness and vision loss between 1990 and 2021: the findings of the Global Burden of Disease Study 2021.

Front Public Health. 2025-4-29

[5]
Potential to improve the burden of age-related macular degeneration: results from the Global Burden of Disease Study 2021.

Eye (Lond). 2025-4-23

[6]
Risk factors for age-related macular degeneration: Updated systematic review and meta-analysis.

Medicine (Baltimore). 2025-2-21

[7]
Impact of Dry Age-Related Macular Degeneration on Daily Activities and Quality of Life: Interview Findings From Patients and Caregivers Relative to a General Population.

Clin Ophthalmol. 2025-2-18

[8]
Burdens and trends of age-related macular degeneration at global, regional, and national levels,1990-2021: findings from the 2021 global burden of disease study.

Eye (Lond). 2025-6

[9]
Association Between C22:5-Containing Lipids and RPE Pathologies in Mice with Tmem135 Overexpression.

Adv Exp Med Biol. 2025

[10]
Global burden of low vision and blindness due to age-related macular degeneration from 1990 to 2021 and projections for 2050.

BMC Public Health. 2024-12-18

本文引用的文献

[1]
Effectiveness of self-financing patient-led support groups in the management of hypertension and diabetes in low- and middle-income countries: Systematic review.

Trop Med Int Health. 2023-2

[2]
Association Between Oral Metformin Use and the Development of Age-Related Macular Degeneration in Diabetic Patients: A Systematic Review and Meta-Analysis.

Invest Ophthalmol Vis Sci. 2022-12-1

[3]
Trends and Disparities in the Incidence of Intraocular Foreign Bodies 1990-2019: A Global Analysis.

Front Public Health. 2022

[4]
The roles of sex and gender in women's eye health disparities in the United States.

Biol Sex Differ. 2021-10-20

[5]
Association of life course socioeconomic status and adult height with cognitive functioning of older adults in India and China.

BMC Geriatr. 2021-6-9

[6]
Age-Related Macular Degeneration.

Med Clin North Am. 2021-5

[7]
Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study.

Lancet Glob Health. 2021-2

[8]
Prevalence and causes of vision loss in China from 1990 to 2019: findings from the Global Burden of Disease Study 2019.

Lancet Public Health. 2020-12

[9]
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.

Lancet. 2020-10-17

[10]
Variations and trends in global disease burden of age-related macular degeneration: 1990-2017.

Acta Ophthalmol. 2021-5

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索